AstraZeneca has admitted that its COVID-19 vaccine can lead to a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). TTS is a condition characterised by blood clots combined with low levels of platelets, which are essential for blood clotting. According to the Centers for Disease Control (CDC), TTS is classified into two tiers based on severity and manifestation.